{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T13:51:20Z","timestamp":1764510680549},"reference-count":103,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Oncol"],"DOI":"10.3892\/ijo.2019.4917","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T11:54:21Z","timestamp":1574337261000},"source":"Crossref","is-referenced-by-count":3,"title":["Molecular and clinical progress in follicular lymphoma lacking the t(14;18) translocation (Review)"],"prefix":"10.3892","author":[{"given":"Zunmin","family":"Zhu","sequence":"first","affiliation":[{"name":"Institute of Hematology, Henan Renmin Hospital, Zhengzhou, Henan 475000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[{"name":"Laboratory of Hematology, The First Affiliated Hospital of Zhenzhou University, Zhengzhou, Henan 475000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuran","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan 450000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengqiang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Immunology Laboratory of Chinese Medicine, Henan University of Chinese Medicine, Zhengzhou, Henan 450008, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dandan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Zhengzhou Shenyou Biotechnology, Zhengzhou, Henan 450000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, MD Anderson Cancer Center, Houston, TX 77030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shichun","family":"Tu","sequence":"additional","affiliation":[{"name":"Scintillon Institute for Biomedical and Bioenergy Research, San Diego, CA 92121, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihong","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan 450000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,11,21]]},"reference":[{"key":"key20200713190123_b1-ijo-56-01-0007","volume-title":"Follicular Lymphoma, Pamphlet","year":"2017"},{"key":"key20200713190123_b2-ijo-56-01-0007","doi-asserted-by":"crossref","unstructured":"Abd El-GhaffarHAShamaaSAttwanNStratification of Patients with Follicular LymphomaIntechOpenRijeka2012https:\/\/www.intechopen.com\/books\/hematology-science-and-practice\/stratification-of-patients-with-follicular-lymphoma. Accessed March 2, 2012","DOI":"10.5772\/35022"},{"key":"key20200713190123_b3-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.1172\/JCI63186","article-title":"Pathogenesis of follicular lymphoma","volume":"122","author":"Kridel","year":"2012","journal-title":"J Clin Invest"},{"key":"key20200713190123_b4-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1158\/0008-5472.CAN-15-0828","article-title":"Elucidation and pharmacological targeting of novel molecular drivers of follicular lymphoma progression","volume":"76","author":"Bisikirska","year":"2016","journal-title":"Cancer Res"},{"key":"key20200713190123_b5-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1182\/blood-2008-07-168682","article-title":"A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p-36","volume":"113","author":"Katzenberger","year":"2009","journal-title":"Blood"},{"key":"key20200713190123_b6-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1182\/blood-2014-04-516815","article-title":"Transformed follicular non-Hodgkin lymphoma","volume":"125","author":"Casulo","year":"2015","journal-title":"Blood"},{"key":"key20200713190123_b7-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1080\/10428190701836845","article-title":"C-MYC translocation in t(14;18) positive follicular lymphoma at presentation: An adverse prognostic indicator?","volume":"49","author":"Christie","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"key20200713190123_b8-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0092-8674(85)80070-2","article-title":"Cloning the chromosomal break-point of t(14;18) human lymphomas: Clustering around Jh on chromosome 14 and near a transcriptional unit on 18","volume":"41","author":"Bakhski","year":"1985","journal-title":"Cell"},{"key":"key20200713190123_b9-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1126\/science.3929382","article-title":"The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining","volume":"229","author":"Tsujimoto","year":"1985","journal-title":"Science"},{"key":"key20200713190123_b10-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"7439","DOI":"10.1073\/pnas.82.21.7439","article-title":"Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18","volume":"82","author":"Cleary","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713190123_b11-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1126\/science.6093263","article-title":"Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation","volume":"226","author":"Tsujimoto","year":"1984","journal-title":"Science"},{"key":"key20200713190123_b12-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1172\/JCI113235","article-title":"Expression of Bcl-2 and Bcl-2-Ig fusion transcripts in normal and neoplastic cells","volume":"80","author":"Graninger","year":"1987","journal-title":"J Clin Invest"},{"key":"key20200713190123_b13-ijo-56-01-0007","first-page":"255","article-title":"Is t(14;18)(q32;q21) a constant finding in follicular lymphoma?","volume":"17","author":"Godon","year":"2003","journal-title":"An interphase FISH study on 63 patients Leukemia"},{"key":"key20200713190123_b14-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1182\/blood.V99.1.282","article-title":"Gene expression profiling of follicular lymphoma and normal germinal center B cells using cDNA arrays","volume":"99","author":"Husson","year":"2002","journal-title":"Blood"},{"key":"key20200713190123_b15-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1111\/j.1365-2141.2008.07528.x","article-title":"BCL2 protein expression in follicular lymphomas with t(14;18) chromosomal translocations","volume":"144","author":"Masir","year":"2009","journal-title":"Br J Haematol"},{"key":"key20200713190123_b16-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1056\/NEJMcibr067155","article-title":"A closer look at follicular lymphoma","volume":"356","author":"Staudt","year":"2007","journal-title":"N Engl J Med"},{"key":"key20200713190123_b17-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1200\/JCO.2013.52.8190","article-title":"t(14;18) Translocation: A predictive blood biomarker for follicular lymphoma","volume":"32","author":"Roulland","year":"2014","journal-title":"J Clin Oncol"},{"key":"key20200713190123_b18-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.3109\/10428194.2014.982638","article-title":"Tumor suppressors in follicular lymphoma","volume":"56","author":"Graham","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"key20200713190123_b19-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/modpathol.2009.81","article-title":"t(14;18)-negative follicular lymphomas are associated with a high frequency of BCL6 rearrangement at the alternative breakpoint region","volume":"22","author":"Gu","year":"2009","journal-title":"Mod Pathol"},{"key":"key20200713190123_b20-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"5580","DOI":"10.1038\/sj.onc.1204640","article-title":"Mechanisms of chromosomal translocations in B cell lymphomas","volume":"20","author":"K\u00fcppers","year":"2001","journal-title":"Oncogene"},{"key":"key20200713190123_b21-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1046\/j.1365-2141.2003.04086.x","article-title":"Follicular lymphoma lacking the t(14;18)(q32;q21): Identification of two disease subtypes","volume":"120","author":"Horsman","year":"2003","journal-title":"Br J Haematol"},{"key":"key20200713190123_b22-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.critrevonc.2008.01.014","article-title":"Follicular lymphomas","volume":"66","author":"Vitolo","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"key":"key20200713190123_b23-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of theWorld Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"key20200713190123_b24-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1109\/TBME.2010.2058111","article-title":"Detection of follicles from IHC-stained slides of follicular lymphoma using iterative watershed","volume":"57","author":"Samsi","year":"2010","journal-title":"IEEE Trans Biomed Eng"},{"key":"key20200713190123_b25-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"5840","DOI":"10.1002\/cncr.27637","article-title":"Driver mutations determine survival in smokers and never-smokers with stage IIIB\/IV lung adenocarcinomas","volume":"118","author":"Paik","year":"2012","journal-title":"Cancer"},{"key":"key20200713190123_b26-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0002-9440(10)63313-5","article-title":"Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component","volume":"165","author":"Katzenberger","year":"2004","journal-title":"Am J Pathol"},{"key":"key20200713190123_b27-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1182\/blood.V99.10.3806","article-title":"Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3","volume":"99","author":"Ott","year":"2002","journal-title":"Blood"},{"key":"key20200713190123_b28-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.3324\/haematol.2011.042531","article-title":"Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profiles","volume":"96","author":"Horn","year":"2011","journal-title":"Haematologica"},{"key":"key20200713190123_b29-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.beha.2011.02.002","article-title":"Follicular lymphoma grade 3B","volume":"24","author":"Salaverria","year":"2011","journal-title":"Best Pract Res Clin Haematol"},{"key":"key20200713190123_b30-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1182\/blood.V101.3.1149","article-title":"Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27, or other translocations: t(14;18) and 3q27 are mutually exclusive","volume":"101","author":"Bosga-Bouwer","year":"2003","journal-title":"Blood"},{"key":"key20200713190123_b31-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3324\/haematol.2009.007203","article-title":"Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP","volume":"95","author":"Shustik","year":"2010","journal-title":"Haematologica"},{"key":"key20200713190123_b32-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/(SICI)1098-2264(200001)27:1<85::AID-GCC11>3.0.CO;2-9","article-title":"Interphase FISH detection of BCL2 rearrangement in follicular lymphoma using breakpoint-flanking probes","volume":"27","author":"Vaandrager","year":"2000","journal-title":"Genes Chromosomes Cancer"},{"key":"key20200713190123_b33-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"530","DOI":"10.2353\/jmoldx.2007.070038","article-title":"'Minor' BCL2 breakpoints in follicular lymphoma: Frequency and correlation with grade and disease presentation in 236 cases","volume":"9","author":"Weinberg","year":"2007","journal-title":"J Mol Diagn"},{"key":"key20200713190123_b34-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1182\/blood-2009-01-198580","article-title":"Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations","volume":"114","author":"Leich","year":"2009","journal-title":"Blood"},{"key":"key20200713190123_b35-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"5550","DOI":"10.1182\/blood-2011-06-361972","article-title":"MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype","volume":"118","author":"Leich","year":"2011","journal-title":"Blood"},{"key":"key20200713190123_b36-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/path.1689","article-title":"Lack of Bcl-2 expression in follicular lymphoma may be caused by mutations in the BCL2 gene or by absence of the t(14;18) translocation","volume":"205","author":"Schraders","year":"2005","journal-title":"J Pathol"},{"key":"key20200713190123_b37-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0046-8177(99)90141-7","article-title":"Bcl-6 and Bcl-2 protein expression in diffuse large B-cell lymphoma and follicular lymphoma: Correlation with 3q27 and 18q21 chromosomal abnormalities","volume":"30","author":"Skinnider","year":"1999","journal-title":"Hum Pathol"},{"key":"key20200713190123_b38-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1440-1827.2006.02072.x","article-title":"Bcl2-negative follicular lymphomas frequently have Bcl6 translocation and\/or Bcl6 or p53 expression","volume":"57","author":"Guo","year":"2007","journal-title":"Pathol Int"},{"key":"key20200713190123_b39-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1038\/sj.leu.2402707","article-title":"Follicular lymphoma without t(14;18) and with BCL-6 rearrangement: A lymphoma subtype with distinct pathological, molecular and clinical characteristics","volume":"16","author":"Jardin","year":"2002","journal-title":"Leukemia"},{"key":"key20200713190123_b40-ijo-56-01-0007","first-page":"4649","article-title":"BCL6-translocations affect the phenotype of follicular lymphomas only in the absence of t(14;18)IgH\/BCL2","volume":"29","author":"Gollub","year":"2009","journal-title":"Anticancer Res"},{"key":"key20200713190123_b41-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/PDM.0b013e3182585c3c","article-title":"Frequencies of BCL2 and BCL6 translocations in representative Chinese follicular lymphoma patients: Morphologic, immunohistochemical, and FISH analyses","volume":"21","author":"Pan","year":"2012","journal-title":"Diagn Mol Pathol"},{"key":"key20200713190123_b42-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1182\/blood-2006-09-045989","article-title":"CD10-MUM1 + follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features","volume":"109","author":"Karube","year":"2007","journal-title":"Blood"},{"key":"key20200713190123_b43-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.3324\/haematol.13239","article-title":"Somatic hyper-mutation of IGVH genes and aberrant somatic hypermutation in follicular lymphoma without BCL-2 gene rearrangement and expression","volume":"93","author":"Gagyi","year":"2008","journal-title":"Haematologica"},{"key":"key20200713190123_b44-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/PAS.0b013e31826b9b57","article-title":"Follicular lymphomas in children and young adults: A comparison of the pediatric variant with usual follicular lymphoma","volume":"37","author":"Liu","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"key20200713190123_b45-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.3324\/haematol.2012.073916","article-title":"Recurrent loss of heterozygosity in 1p36 associated with TNFRSF14 mutations in IRF4 translocation negative pediatric follicular lymphomas","volume":"98","author":"Martin-Guerrero","year":"2013","journal-title":"Haematologica"},{"key":"key20200713190123_b46-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1182\/asheducation-2009.1.523","article-title":"The 2008 WHO classification of lymphomas: Implications for clinical practice and translational research","author":"Jaffe","year":"2009","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"key20200713190123_b47-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1182\/blood-2012-05-429514","article-title":"Pediatric-type nodal follicular lymphoma: An indolent clonal proliferation in children and adults with high proliferation index and no BCL2 rearrangement","volume":"120","author":"Louissaint","year":"2012","journal-title":"Blood"},{"key":"key20200713190123_b48-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2217\/epi.15.96","article-title":"Epigenetic dysregulation in follicular lymphoma","volume":"8","author":"Araf","year":"2016","journal-title":"Epigenomics"},{"key":"key20200713190123_b49-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1038\/bcj.2013.26","article-title":"Lessons from next-generation sequencing analysis in hematological malignancies","volume":"3","author":"Braggio","year":"2013","journal-title":"Blood Cancer J"},{"key":"key20200713190123_b50-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1182\/blood-2015-10-679191","article-title":"TNFRSF14 aberrations in follicular lymphoma increase clinically significant allogeneic T-cell responses","volume":"128","author":"Kotsiou","year":"2016","journal-title":"Blood"},{"key":"key20200713190123_b51-ijo-56-01-0007","first-page":"1860","article-title":"Report of the committee on Hodgkin's disease staging classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res"},{"key":"key20200713190123_b52-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1200\/JCO.1998.16.8.2780","article-title":"New approach to classifying non-Hodgkin's lymphomas: Clinical features of the major histo-logic subtypes. Non-Hodgkin's lymphoma classification project","volume":"16","author":"Armitage","year":"1998","journal-title":"J Clin Oncol"},{"key":"key20200713190123_b53-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1056\/NEJM198412063112303","article-title":"The natural history of initially untreated low-grade non-Hodgkin's lymphomas","volume":"311","author":"Horning","year":"1984","journal-title":"N Engl J Med"},{"key":"key20200713190123_b54-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3960\/jslrt.54.3","article-title":"Pathology of follicular lymphoma","volume":"54","author":"Takata","year":"2014","journal-title":"J Clin Exp Hematop"},{"key":"key20200713190123_b55-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1182\/blood-2012-07-441253","article-title":"A promising new biologic prognostic model in diffuse large B-cell lymphoma","volume":"120","author":"Nathwani","year":"2012","journal-title":"Blood"},{"key":"key20200713190123_b56-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/bjc.1992.16","article-title":"Evaluation of bcl-2 protein expression and 14;18 translocation as prognostic markers in follicular lymphoma","volume":"65","author":"Pezella","year":"1992","journal-title":"Br J Cancer"},{"key":"key20200713190123_b57-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/bjh.12281","article-title":"R-CHOP therapy alone in limited stage diffuse large B-cell lymphoma","volume":"161","author":"Tomita","year":"2013","journal-title":"Br J Haematol"},{"key":"key20200713190123_b58-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1756-8722-2-14","article-title":"R-CHOP versus R-CVP in the treatment of follicular lymphoma: A meta-analysis and critical appraisal of current literature","volume":"2","author":"Siddhartha","year":"2009","journal-title":"J Hematol Oncol"},{"key":"key20200713190123_b59-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"6624","DOI":"10.1158\/1078-0432.CCR-13-1120","article-title":"A comparative analysis of prognostic factor models for follicular lymphoma based on a phase III trial of CHOP-rituximab versus CHOP + 131iodine-tositumomab","volume":"19","author":"Press","year":"2013","journal-title":"Clin Cancer Res"},{"key":"key20200713190123_b60-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1182\/blood-2015-11-624288","article-title":"Follicular lymphoma: Evolving therapeutic strategies","volume":"127","author":"Kahl","year":"2016","journal-title":"Blood"},{"key":"key20200713190123_b61-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1182\/blood.V90.6.2188","article-title":"IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma","volume":"90","author":"Maloney","year":"1997","journal-title":"Blood"},{"key":"key20200713190123_b62-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","article-title":"Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: Half of patients respond to a four-dose treatment program","volume":"16","author":"McLaughlin","year":"1998","journal-title":"J Clin Oncol"},{"key":"key20200713190123_b63-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13045-015-0224-3","article-title":"ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development","volume":"8","author":"Cang","year":"2015","journal-title":"J Hematol Oncol"},{"key":"key20200713190123_b64-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1038\/sj.onc.1208349","article-title":"Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: Implications in chemosensitization and therapeutic intervention","volume":"24","author":"Jazirehi","year":"2005","journal-title":"Oncogene"},{"key":"key20200713190123_b65-ijo-56-01-0007","first-page":"709","article-title":"Inhibition of interleukin 10 by rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis","volume":"7","author":"Alas","year":"2001","journal-title":"Clin Cancer Res"},{"key":"key20200713190123_b66-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/leu.2015.330","article-title":"Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus","volume":"30","author":"Leich","year":"2016","journal-title":"Leukemia"},{"key":"key20200713190123_b67-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"key20200713190123_b68-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3960\/jslrt.53.107","article-title":"The 3q27 and 18q21 translocations for follicular lymphoma and diffuse large B-cell lymphoma in the rituximab era","volume":"53","author":"Watanabe","year":"2013","journal-title":"J Clin Exp Hematop"},{"key":"key20200713190123_b69-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1365-2559.2006.02501.x","article-title":"BCL2 gene abnormalities define distinct clinical subsets of follicular lymphoma","volume":"49","author":"Goodlad","year":"2006","journal-title":"Histopathology"},{"issue":"1 Suppl","key":"key20200713190123_b70-ijo-56-01-0007","first-page":"S207","article-title":"A case of t(14;18)-negative follicular lymphoma with unusual immunopheno-type: A diagnostic dilemma","volume":"6","author":"Wong","year":"2011","journal-title":"Med Health"},{"key":"key20200713190123_b71-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"e0151735","DOI":"10.1371\/journal.pone.0151735","article-title":"Isolated follicles enriched for centroblasts and lacking t(14;18)\/BCL2 in lymphoid tissue: Diagnostic and clinical implications","volume":"11","author":"Nybakken","year":"2016","journal-title":"PLoS One"},{"key":"key20200713190123_b72-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.ajoms.2013.09.008","article-title":"A case of surgical treatment for primary BCL2-'negative' follicular lymphoma without t(14;18) in early stage of the submandibular lymph node","volume":"26","author":"Kamatani","year":"2014","journal-title":"J Oral Maxillofac Surg Med Pathol"},{"key":"key20200713190123_b73-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1172\/JCI85795","article-title":"Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma","volume":"126","author":"Cardenas","year":"2016","journal-title":"J Clin Invest"},{"key":"key20200713190123_b74-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nrm3255","article-title":"Regulating the regulator: Post-translational modification of RAS","volume":"13","author":"Ahearn","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20200713190123_b75-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1182\/blood-2013-05-500595","article-title":"Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma","volume":"123","author":"Bouska","year":"2014","journal-title":"Blood"},{"key":"key20200713190123_b76-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1182\/blood-2013-05-500264","article-title":"Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma","volume":"123","author":"Li","year":"2014","journal-title":"Blood"},{"key":"key20200713190123_b77-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"12520","DOI":"10.1073\/pnas.92.26.12520","article-title":"Frequent somatic hypermutation of the 5' noncoding region of the BCL6 gene in B-cell lymphoma","volume":"92","author":"Migliazza","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713190123_b78-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1158\/1078-0432.CCR-13-2175","article-title":"Inactivation of the CDKN2A tumor-suppressor gene by deletion or methylation is common at diagnosis in follicular lymphoma and associated with poor clinical outcome","volume":"20","author":"Alhejaily","year":"2014","journal-title":"Clin Cancer Res"},{"key":"key20200713190123_b79-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"9166","DOI":"10.1158\/0008-5472.CAN-10-2460","article-title":"Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis","volume":"70","author":"Cheung","year":"2010","journal-title":"Cancer Res"},{"key":"key20200713190123_b80-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1038\/sj.leu.2404696","article-title":"Genome-wide detection of recurring sites of uniparental disomy in follicular and transformed follicular lymphoma","volume":"21","author":"Fitzgibbon","year":"2007","journal-title":"Leukemia"},{"key":"key20200713190123_b81-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1084\/jem.20132120","article-title":"Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy","volume":"211","author":"Oricchio","year":"2014","journal-title":"J Exp Med"},{"key":"key20200713190123_b82-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.celrep.2013.12.027","article-title":"Genetics of follicular lymphoma transformation","volume":"6","author":"Pasqualucci","year":"2014","journal-title":"Cell Rep"},{"key":"key20200713190123_b83-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.1158\/1078-0432.CCR-07-0456","article-title":"Comprehensive analysis of copy number and allele status identifies multiple chromosome defects underlying follicular lymphoma pathogenesis","volume":"13","author":"Ross","year":"2007","journal-title":"Clin Cancer Res"},{"key":"key20200713190123_b84-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/gcc.20617","article-title":"Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status","volume":"48","author":"Schwaenen","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"key20200713190123_b85-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/bjh.12819","article-title":"A multicentre phase II study of vorinostat in patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma","volume":"165","author":"Ogura","year":"2014","journal-title":"Br J Haematol"},{"key":"key20200713190123_b86-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/ng.2856","article-title":"Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma","volume":"46","author":"Okosun","year":"2014","journal-title":"Nat Genet"},{"key":"key20200713190123_b87-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s12032-012-0441-3","article-title":"Prognostic significance of epigenetic inactivation of p16, p15, MGMT and DAPK genes in follicular lymphoma","volume":"30","author":"Krajnovic","year":"2013","journal-title":"Med Oncol"},{"key":"key20200713190123_b88-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma","volume":"476","author":"Morin","year":"2011","journal-title":"Nature"},{"key":"key20200713190123_b89-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/ng.518","article-title":"Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin","volume":"42","author":"Morin","year":"2010","journal-title":"Nat Genet"},{"key":"key20200713190123_b90-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1182\/blood.V92.9.3018","article-title":"Somatic Fas mutations in non-Hodgkin's lymphoma: Association with extranodal disease and autoimmunity","volume":"92","author":"Gr\u00f8nbaek","year":"1998","journal-title":"Blood"},{"key":"key20200713190123_b91-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/hmg\/ddv450","article-title":"Folliculin, a tumor suppressor associated with Birt-Hogg-Dube (BHD) syndrome, is a novel modifier of TDP-43 cytoplasmic translocation and aggregation","volume":"25","author":"Xia","year":"2016","journal-title":"Hum Mol Genet"},{"key":"key20200713190123_b92-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1182\/blood.V85.9.2528.bloodjournal8592528","article-title":"Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals","volume":"85","author":"Limpens","year":"1995","journal-title":"Blood"},{"key":"key20200713190123_b93-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1182\/blood.V99.7.2562","article-title":"Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma","volume":"99","author":"Zhu","year":"2002","journal-title":"Blood"},{"key":"key20200713190123_b94-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/sj.leu.2403216","article-title":"SOCS1 and SHP1 hypermethylation in mantle cell lymphoma and follicular lymphoma: Implications for epigenetic activation of the Jak\/STAT pathway","volume":"18","author":"Chim","year":"2004","journal-title":"Leukemia"},{"key":"key20200713190123_b95-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1097\/01.LAB.0000106503.65258.2B","article-title":"Activated proliferation of B-cell lymphomas\/leukemias with the SHP1 gene silencing by aberrant CpG methylation","volume":"83","author":"Koyama","year":"2003","journal-title":"Lab Invest"},{"key":"key20200713190123_b96-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/S0002-9440(10)62535-7","article-title":"Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas\/leukemias: Combination analysis with cDNA expression array and tissue microarray","volume":"159","author":"Oka","year":"2001","journal-title":"Am J Pathol"},{"key":"key20200713190123_b97-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1182\/blood-2008-12-194852","article-title":"TNFAIP3\/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas","volume":"114","author":"Honma","year":"2009","journal-title":"Blood"},{"key":"key20200713190123_b98-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/nature07969","article-title":"Frequent inactivation of A20 in B-cell lymphomas","volume":"459","author":"Kato","year":"2009","journal-title":"Nature"},{"key":"key20200713190123_b99-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.1182\/blood-2009-06-225839","article-title":"Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B-cell lymphoma entities","volume":"114","author":"Mottok","year":"2009","journal-title":"Blood"},{"key":"key20200713190123_b100-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/gcc.20780","article-title":"High resolution analysis of follicular lymphoma genomes reveals somatic recurrent sites of copy-neutral loss of heterozygosity and copy number alterations that target single genes","volume":"49","author":"Cheung","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"key20200713190123_b101-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/leu.2011.266","article-title":"High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosis","volume":"26","author":"Launay","year":"2012","journal-title":"Leukemia"},{"key":"key20200713190123_b102-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1182\/blood-2008-05-154013","article-title":"The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival","volume":"112","author":"O'Shea","year":"2008","journal-title":"Blood"},{"key":"key20200713190123_b103-ijo-56-01-0007","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1182\/blood.V82.7.1994.1994","article-title":"p53 mutation is associated with progression in follicular lymphoma","volume":"82","author":"Sander","year":"1993","journal-title":"Blood"}],"container-title":["International Journal of Oncology"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T19:06:39Z","timestamp":1594667199000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ijo.2019.4917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,21]]},"references-count":103,"URL":"https:\/\/doi.org\/10.3892\/ijo.2019.4917","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,21]]}}}